BeStock  

Amylyx Pharmaceuticals AMLX

US equityMarket cap rank #2350Drug Manufacturers - Specialty & Generic
$26.02 −$0.18 (-0.69%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.55 -1.81%
Open$25.64
Prev close$26.20
Day range$25.52 – $26.40
Volume1.14M
Market cap$3.35B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-21.2x
CheapRich

Near the bottom of its 5-year range · 3rd percentile, 5-year average 23.9x

Price / book5.2x
CheapRich

Above its usual level · 65th percentile, 5-year average 4.5x

#4404 of 5330 stocks by PB (1 = cheapest)

Price / sales-5,855.9x
CheapRich

Near the bottom of its 5-year range · 3rd percentile, 5-year average -516.6x

P/E over five years

-163x118x400x682xJan '22Jun '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$24.50
Price vs. fair value+6.2%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 5.17 – 4.48 65% (pricier than usual) #4404 of 5330 (1 = cheapest)
PE -21.18 -22.39 23.86 3% (cheaper than usual) –
PS -5,855.90 319.12 -516.58 3% (cheaper than usual) –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on AMLX.

Sign in to join the discussion.

Scroll to Top